White Market Drugs
★★★★★
★★★★★
Regular price
€27.50
Regular price
€31.99
Sale
Sale price
€27.50
A01=David Herzberg
abuse
access
Age Group_Uncategorized
Age Group_Uncategorized
amphetamine
Author_David Herzberg
automatic-update
barbiturate
bayer
big pharma
Category1=Non-Fiction
Category=KND
Category=MBX
Category=MKG
Category=MKZR
Category=MMG
Category=MMZR
class
consumer protection
COP=United States
criminalization
Delivery_Delivery within 10-20 working days
drug addiction
eq_business-finance-law
eq_isMigrated=2
eq_non-fiction
healthcare
heroin
history
inequality
inequity
Language_English
legal system
legislation
medical research
medicine
narcotics
nonfiction
opioid crisis
overdose
oxycontin
PA=Available
pharmaceutical policy
politics
prescription drugs
Price_€20 to €50
privilege
profitability
prohibition
PS=Active
purdue
quaaludes
race
recovery
rehab
relapse
safety
sociology
softlaunch
systemic racism
treatment
wealth
whiteness
Product details
- ISBN 9780226731889
- Dimensions: 152 x 229mm
- Publication Date: 12 Nov 2020
- Publisher: The University of Chicago Press
- Publication City/Country: US
- Product Form: Hardback
- Language: English
Delivery/Collection within 10-20 working days
Our Delivery Time Frames Explained
2-4 Working Days: Available in-stock
10-20 Working Days: On Backorder
Will Deliver When Available: On Pre-Order or Reprinting
We ship your order once all items have arrived at our warehouse and are processed. Need those 2-4 day shipping items sooner? Just place a separate order for them!
The contemporary opioid crisis is widely seen as new and unprecedented. Not so. It is merely the latest in a long series of drug crises stretching back over a century. In White Market Drugs, David Herzberg explores these crises and the drugs that fueled them, from Bayer's Heroin to Purdue's OxyContin and all the drugs in between: barbiturate "goof balls," amphetamine "thrill pills," the "love drug" Quaalude, and more. As Herzberg argues, the vast majority of American experiences with drugs and addiction have taken place within what he calls "white markets," where the prescription of addictive drugs is legal and medically approved. These markets are widely acknowledged but no one has explained how they became so central to the medical system in a nation famous for its "drug wars"--until now. Drawing from federal, state, industry, and medical archives alongside a wealth of published sources, Herzberg re-connects America's divided drug history, telling the whole story for the first time. He reveals that the driving question for policymakers has never been how to prohibit the use of addictive drugs, but how to ensure their availability in medical contexts, where profitability often outweighs public safety. Access to white markets was thus a double-edged sword for socially privileged consumers, even as communities of color faced exclusion and punitive drug prohibition. To counter this no-win setup, Herzberg advocates for a consumer protection approach that robustly regulates all drug markets while caring for people with addiction by ensuring them safe, reliable access to medication-assisted treatment. Accomplishing this requires rethinking a drug/medicine divide born a century ago that, unlike most policies of that racially segregated era, has somehow survived relatively unscathed into the twenty-first century.
By showing how the twenty-first-century opioid crisis is only the most recent in a long history of similar crises of addiction to pharmaceuticals, Herzberg forces us to rethink our most basic ideas about drug policy and addiction itself--ideas that have been failing us catastrophically for over a century.
David Herzberg is associate professor of history at the University at Buffalo. He is the author of Happy Pills in America: From Miltown to Prozac.
Qty: